[1]
|
Amin, M.B. (2016) AJCC Cancer Staging Manual. 8th Edition, Springer, New York.
|
[2]
|
Oliveira, I.S., Kilcoyne, A., Everett, J.M., et al. (2017) Cholangiocarcinoma: Classification, Diagnosis, Staging, Imaging Features, and Management. Abdominal Radiology (NY), 42, 1637-1649.
https://doi.org/10.1007/s00261-017-1094-7
|
[3]
|
Ni, Q., Wang, H., Zhang, Y., et al. (2017) MDCT Assessment of Resectability in Hilar Cholangiocarcinoma. Abdominal Radiology (NY), 42, 851-860. https://doi.org/10.1007/s00261-016-0943-0
|
[4]
|
Bismuth, H., Nakache, R. and Diamond, T. (2015) Management Strategies in Resection for Hilar Cholangiocarcinoma. Annals of Surgery, 215, 31-38. https://doi.org/10.1097/00000658-199201000-00005
|
[5]
|
中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013版) [J]. 中华外科杂志, 2013, 51(10): 865-871.
|
[6]
|
Berardi, R., Mocchegiani, F., Pierantoni, C., et al. (2013) Resected Biliary Tract Cancers: A Novel Clini-cal-Pathological Score Correlates with Global Outcome. Digestive and Liver Disease, 45, 70-74. https://doi.org/10.1016/j.dld.2012.08.012
|
[7]
|
Juntermanns, B., Radunz, S., Heuer, M., et al. (2010) Tumor Mark-ers as a Diagnostic Key for Hilar Cholangiocarcinoma. European Journal of Medical Research, 15, 357-361. https://doi.org/10.1186/2047-783X-15-8-357
|
[8]
|
Valls, C., Ruiz, S., Martinez, L., et al. (2013) Radiological Di-agnosis and Staging of Hilar Cholangiocarcinoma. World Journal of Gastrointestinal Oncology, 5, 115-126. https://doi.org/10.4251/wjgo.v5.i7.115
|
[9]
|
Xu, H.X., Chen, L.D., Xie, X.Y., et al. (2010) Enhancement Pattern of Hilar Cholangiocarcinoma: Contrast-Enhanced Ultrasound versus contrast-Enhanced Computed Tomography. European Journal of Radiology, 75, 197-202.
https://doi.org/10.1016/j.ejrad.2009.04.060
|
[10]
|
Ruys, A.T., Beem, B.E., Engelbrecht, M.R., et al. (2012) Radio-logical Staging in Patients with Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. The British Journal of Radiology, 85, 1255-1262.
https://doi.org/10.1259/bjr/88405305
|
[11]
|
Park, S.J., Kim, T.K., et al. (2001) Three-Dimensional Spiral CT Chol-angiography with Minimum Intensity Projection in Patients with Suspected Obstructive Biliary Disease: Comparison with Percutaneous Transhepatic Cholangiography. Abdominal Imaging, 26, 281-286. https://doi.org/10.1007/s002610000140
|
[12]
|
Chryssou, E., Guthe, J.A., Ward, J., et al. (2010) Hilar Cholangiocar-cinoma: MR Correlation with Surgical and Histological Findings. Clinical Radiology, 65, 781-788. https://doi.org/10.1016/j.crad.2010.04.018
|
[13]
|
Gui, X.Y. and Chen, H.W. (2010) Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Extrahepatic Cholangiocarcinoma. World Journal of Gastroenterology, 16, 3196-3201.
https://doi.org/10.3748/wjg.v16.i25.3196
|
[14]
|
Li, J., Kuehl, H., et al. (2008) Preoperative Assessment of Hilar Cholangiocarcinoma by Dual-Modality PET/CT. Journal of Surgical Oncology, 98, 438-443. https://doi.org/10.1002/jso.21136
|
[15]
|
范莹, 吴硕东. 《2014年美国肝胆胰学会共识声明: 肝门部胆管癌管理》摘译[J]. 临床肝胆病杂志, 2015, 31(10): 1588-1591. https://doi.org/10.3969/J.Issn.1001-5256.2015.10.006
|
[16]
|
Ma, K.W., Cheung, T.T., She, W.H., et al. (2018) Di-agnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tractcancer. World Journal of Surgery, 42, 823-834.
https://doi.org/10.1007/s00268-017-4192-3
|
[17]
|
刘元进, 张永杰. 梗阻性黄疸行胆道引流前后肝脏的病理生理变化[J]. 肝胆胰外科杂志, 2018, 30(5): 436-440.
|
[18]
|
Liu, F., Li, Y., Wei, Y., et al. (2011) Preoperative Biliary D Rainage before Resection for Hilar Cholangiocarcinoma: Whether or Not? A Systematic Review. Digestive Diseases and Sciences, 56, 663-672.
https://doi.org/10.1007/s10620-010-1338-7
|
[19]
|
Farges, O., Regimbeau, J.M., Fuks, D., et al. (2013) Multicentre European Study of Preoperative Biliary Drainage for Hilar Cholangiocarcinoma. British Journal of Surgery, 100, 274-284. https://doi.org/10.1002/bjs.8950
|
[20]
|
黄志强. 肝门部胆管癌外科治疗面临的问题与出路[J]. 中华实验外科杂志, 2004, 21(7): 773-775.
|
[21]
|
Makuuchi, M., Thai, B.L., Takayasu, K., et al. (1990) Preoperative Portal Embolization to Increase Safety of Major Hepatectomy for Hilarbile Duct Carcinoma: A Preliminary Report. Surgery, 107, 521-527.
|
[22]
|
Kotenko, O.G., Kondratiuk, V.A., Fedorov, D.A., et al. (2014) Preoperative Portal Vein Emboliza-tion: Dynamics of Portal Pressure. Klinichna khirurhiia, 18, 37-39.
|
[23]
|
Higuchi, R. and Yamamoto, M. (2014) Indica-tions for Portal Vein Embolization in Perihilar Cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 21, 542-549. https://doi.org/10.1002/jhbp.77
|
[24]
|
Ebata, T., Yokoyama, Y., Igami, T., et al. (2012) Portal Vein Embo-lization before Extended Hepatectomy for Biliary Cancer: Current Technique and Review of 494 Consecutive Emboliza-tions. Digestive Surgery, 29, 23-29.
https://doi.org/10.1159/000335718
|
[25]
|
Guiu, B., Bize, P., Demartines, N., et al. (2014) Simultaneous Biliary Drainage and Portal Vein Embolization before Emended Hepatectomy for Hilar Cholangiocarcinoma: Preliminary Expe-rience. CardioVascular and Interventional Radiology, 37, 698-704. https://doi.org/10.1007/s00270-013-0699-7
|
[26]
|
邢冬娟, 徐爱民, 易滨, 等. 术前门静脉栓塞术在肝门部胆管癌扩大肝切除术中的应用研究[J]. 肝胆外科杂志, 2011, 19(6): 415-419.
|
[27]
|
王征, 樊嘉, 周俭. ALPPS在肝脏外科的应用前景[J]. 肝胆外科杂志, 2015, 23(1): 1-2.
|
[28]
|
Izbicki, J.R., Tsui, T.Y., Bohn, B.A., et al. (2013) Surgical Strategies in Patients with Advanced Hilar ChoL-angiocarcinoma (Klatskin Tumor). Journal of Gastrointestinal Surgery, 17, 581-585.
https://doi.org/10.1007/s11605-012-2109-x
|
[29]
|
Forsmo, H.M., Horn, A., Viste, A., et al. (2008) Survival and an Overview of Decision-Making in Patients with Cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International, 7, 412-417.
|
[30]
|
Cannon, R.M., Brock, G. and Buell, J.F. (2012) Surgical Resection for Hilar Cholangiocarcinoma: Ex-perience Improves Resectability. HPB (Oxford), 14, 142-149. https://doi.org/10.1111/j.1477-2574.2011.00419.x
|
[31]
|
晏益核, 黄玉斌, 蔡小勇. 肝门部胆管癌的外科治疗现状[J]. 中国普通外科杂志, 2017, 26(2): 246-251.
|
[32]
|
Chen, X.P., Lau, W.Y., Huang, Z.Y., et al. (2009) Extent of Liver Resection for Hilar Cholangiocarcinoma. British Journal of Surgery, 96, 1167-1175. https://doi.org/10.1002/bjs.6618
|
[33]
|
Xiang, S., Lau, W.Y. and Chen, X.P. (2015) Hilar Cholangiocarcinoma: Controversies on the Extent of Surgical Resection Aiming at Cure. International Journal of Colorectal Disease, 30, 159-171.
https://doi.org/10.1007/s00384-014-2063-z
|
[34]
|
Wahab, M.A., Sultan, A.M., Salah, T., et al. (2012) Caudate Lobe Resection with Major Hepatectomy for Central Cholangiocarcinoma: Is It of Value. Hepatogastroenterology, 59, 321-314. https://doi.org/10.5754/hge11999
|
[35]
|
Endo, L., Matsuyama, R., Taniguchi, K., et al. (2012) Right Hepa-tectomy with Resection of Caudate Lobe and Extrahepatic Bile Duct for Hilar Cholangiocarcinoma. Journal of Hepa-to-Biliary-Pancreatic Sciences, 19, 216-224.
https://doi.org/10.1007/s00534-011-0481-7
|
[36]
|
鲁正, 王冬冬. Bismuth-Corlettem、IV型肝门部胆管癌的手术治疗方式[J]. 中华外科杂志, 2016, 54(7): 488-491.
|
[37]
|
Igami, T., Nishio, H., Ebata, T., et al. (2010) Surgical Treat-ment of Hilar Cholangiocarcinoma in the New Era: The Nagoya University Experience. Journal of Hepa-to-Biliary-Pancreatic Sciences, 17, 449-454.
https://doi.org/10.1007/s00534-009-0209-0
|
[38]
|
Lumgart, L.H., Hadjis, N.S., Benjamin, I.S., et al. (1984) Surgical Approaches to Cholangiocarcinoma at Confluence of Hepatic Ducts. The Lancet, 1, 66-70. https://doi.org/10.1016/S0140-6736(84)90002-3
|
[39]
|
Beazley, R.M., Hadjis, N., Benjamin, I.S., et al. (1984) Clinicopathological Aspects of High Bile Duct Cancer. Experience with Resection and Bypass Surgical Treatments. An-nals of Surgery, 199, 623-636.
https://doi.org/10.1097/00000658-198406000-00001
|
[40]
|
梁廷波, 白雪莉. 肝门部胆管癌多学科团队的诊断与治疗[J]. 中华消化外科杂志, 2015, 14(4): 268-274.
|
[41]
|
郁晓峰, 龚先锋, 张洋, 等. 联合血管切除在手术治疗肝门部胆管癌中作用的Meta分析[J]. 中国普通外科杂志, 2016, 25(2): 162-174.
|
[42]
|
潘海燕, 苏永辉, 贾英斌, 等. 肝门部胆管癌根治术联合血管切除后血管重建11例临床观察[J]. 实用癌症杂志, 2013, 28(5): 562-564.
|
[43]
|
Ebata, T., Ito, T., Yokoyama, Y., et al. (2014) Surgical Technique of Hepatectomy Combined with Sim-ultaneous Resection of Hepatic Artery and Portal Vein for Perihilar Cholangiocarcinoma (with Video). Journal of Hepa-to-Biliary- Pancreatic Sciences, 21, E57-E61. https://doi.org/10.1002/jhbp.121
|
[44]
|
陈志宇, 别平. 联合血管切除与重建在肝门部胆管癌外科治疗中的应用[J]. 临床肝胆病杂志, 2016, 32(7): 1277-1279.
|
[45]
|
Jonas, S., Kling, N., Guckelberger, O., et al. (1998) Orthotopic Liver Transplantation after Extended Bile Duct Resection as Treatment of Hilar Cholangiocarcinoma. First Long-Terms Results. Transplant International, 11, S206-S208.
https://doi.org/10.1111/j.1432-2277.1998.tb01116.x
|
[46]
|
Conci, S., Ruzzenente, A., Sandri, M., et al. (2017) What Is the Most Accurate Lymph Node Staging Method for Perihilar Cholangiocarcinoma? Comparison of UICC/AJCC PN Stage, Number of Metastatic Lymph Nodes, Lymph Node Ratio, and Log Odds of Metastatic Lymph Nodes. European Journal of Surgical Oncology, 43, 743-750.
https://doi.org/10.1016/j.ejso.2016.12.007
|
[47]
|
Giuliante, F., Ardito, F., Guglielmi, A., et al. (2016) Association of Lymph Node Status with Survival in Patients after Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis. JAMA Surgery, 151, 916-922.
https://doi.org/10.1001/jamasurg.2016.1769
|
[48]
|
Bagante, F., Tran, T., Spolverato, G., et al. (2016) Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. Journal of the Ameri-can College of Surgeons, 222, 750-759.
https://doi.org/10.1016/j.jamcollsurg.2016.02.012
|
[49]
|
Aoba, T., Ebata, T., Yokoyama, Y., et al. (2013) Assess-ment of Nodal Status for Perihilar Cholangiocarcinoma: Location, Number, or Ratio of Involved Nodes. Annals of Sur-gery, 257, 718-725.
https://doi.org/10.1097/SLA.0b013e3182822277
|
[50]
|
Ratti, F., Cipriani, F., Ariotti, R., et al. (2016) Safety and Feasibility of Laparoscopic Liver Resection with Associated Lymphadenectomy for Intrahepatic Cholangiocarcinoma: A Propensity Score Based Case Matched Analysis from a Single Institution. Surgical Endoscopy, 30, 1999-2010. https://doi.org/10.1007/s00464-015-4430-4
|
[51]
|
戴朝六, 龚正, 贾昌俊, 等. 术前门静脉栓塞在Ⅳ型肝门胆管癌的应用价值探讨[J]. 中国实用外科杂志, 2012, 32(11): 924-927.
|
[52]
|
王琛, 刘永永. 肝门部胆管癌手术方式的选择及手术方法的探讨[J]. 国际外科学杂志, 2017, 44(7): 439-441.
|
[53]
|
De Jong, M.C., Marques, H., Clary, B.M., et al. (2012) The Impact of Portal Vein Resection on Outcomes for Hilar Cholangiocarcinoma: A Multi-Institutional Analysis of 305 Cases. Cancer, 118, 4737-4747.
https://doi.org/10.1002/cncr.27492
|
[54]
|
Dumitrascu, T., Stroescu, C., Brasoveanu, V., et al. (2017) Curative-Intent Surgery for Perihilar Cholangiocarcinoma with and without Portal Vein Resection—A Comparative Analysis of Early and Late Outcomes. Chirurgia (Bucur), 112, 308-319. https://doi.org/10.21614/chirurgia.112.3.308
|
[55]
|
Lee, R.M. and Maithel, S.K. (2019) Approaches and Outcomes to Distal Cholangiocarcinoma. Surgical Oncology Clinics of North America, 28, 631-643. https://doi.org/10.1016/j.soc.2019.06.014
|
[56]
|
Blechacz, B. (2017) Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver, 11, 13-26.
https://doi.org/10.5009/gnl15568
|
[57]
|
Valle, J.W., Furuse, J., Jitlal, M., et al. (2014) Cisplatin and Gemcitabine for Advanced Biliary Tract Cancer: A Meta-Analysis of Two Randomised Trials. Annals of Oncology, 25, 391-398. https://doi.org/10.1093/annonc/mdt540
|
[58]
|
Turgeon, M.K. and Maithel, S.K. (2020) Cholangiocarcinoma: A Site-Specific Update on the Current State of Surgical Management and Multimodality Therapy. Chinese Clinical Oncolo-gy, 9, Article No. 4.
https://doi.org/10.21037/cco.2019.08.09
|
[59]
|
Iyer, P., Chen, M.H., Goyal, L., et al. (2020) Targets for Therapy in Biliary Tract Cancers: The New Horizon of Personalized Medicine. Chinese Clinical Oncology, 9, Article No. 7. https://doi.org/10.21037/cco.2019.12.11
|
[60]
|
Montal, R., Sia, D., Montironi, C., et al. (2020) Molecular Classifica-tion and Therapeutic Targets in Extrahepatic Cholangiocarcinoma. Journal of Hepatology, 73, 315-327. https://doi.org/10.1016/j.jhep.2020.03.008
|
[61]
|
Parodi, A., Fisher, D., Giovannini, M., et al. (2012) Endoscopic Management of Hilar Cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology, 9, 105-112. https://doi.org/10.1038/nrgastro.2011.271
|
[62]
|
Jung, C., Lavole, J., Barret, M., et al. (2019) Local Therapy in Ad-vanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options. Oncology, 97, 191-201. https://doi.org/10.1159/000500832
|
[63]
|
Singh, A. and Siddiqui, U.D. (2015) The Role of Endoscopy in the Diagnosis and Management of Cholangiocarcinoma. Journal of Clinical Gastroenterology, 49, 725-737. https://doi.org/10.1097/MCG.0000000000000390
|
[64]
|
Monkemuller, K., Popa, D. and Wilcox, C.M. (2014) En-doscopic Treatment Options for Cholangiocarcinomas. Expert Review of Anticancer Therapy, 14, 407-418. https://doi.org/10.1586/14737140.2014.870480
|